Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

CSM statistician Peter Dutton has developed a software package that optimises the design of single-arm clinical trials in rare diseases.

Head and shoulders photograph of Peter Dutton alongside four example graph outputs from the developed software.
The newly developed software helps to choose the number of participants that a trial needs to have a good chance of finding out whether the drug under investigation works (green) or is too toxic to use (red) without needing more participants (yellow).